Cargando…
HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON’S DISEASE
INTRODUCTION: Homocysteine is process-product of methionine demethylation. It has proatherogenic, prothrombotic, prooxidative, proapoptotic, osteoporotic, neurotoxic, neuroinflamatory, and neurodegenerative effects. Hyperhomocysteinemia correlates with C667T MTHFR mutation, decrease of folic acid an...
Autores principales: | Ibrahimagic, Omer C., Smajlovic, Dzevdet, Dostovic, Zikrija, Pasic, Zejneba, Kunic, Suljo, Iljazovic, Amra, Hajdarevic, Denisa Salihovic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVICENA, d.o.o., Sarajevo
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034996/ https://www.ncbi.nlm.nih.gov/pubmed/27698607 http://dx.doi.org/10.5455/msm.2016.28.303-306 |
Ejemplares similares
-
Psychological Stress and Changes of Hypothalamic-Pituitary-Adrenal Axis in Patients with “De Novo” Parkinson’s Disease
por: Ibrahimagic, Omer C., et al.
Publicado: (2016) -
Cognitive Disorders in Patients with Multiple Sclerosis
por: Sehanovic, Aida, et al.
Publicado: (2020) -
Acute Stroke Patients with Sleep Apnea Acording to the Disability and Incidence of Relapse
por: Kojic, Biljana, et al.
Publicado: (2021) -
Risk Factors in Acute Stroke Patients With and Without Sleep Apnea
por: Kojic, Biljana, et al.
Publicado: (2021) -
Comment on an article: “COVID-19 disease will cause a global catastrophe in terms of mental health: A hypothesis”
por: Ibrahimagić, Omer Ć., et al.
Publicado: (2020)